Evidence map›Paper›PMID 25305352›Full record

Trial reportThe Journal of steroid biochemistry and molecular biology2015

Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.

Angeline A Giangreco, Shweta Dambal, Dennis Wagner, Theodorus Van der Kwast, Reinhold Vieth, Gail S Prins, Larisa Nonn

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of steroid biochemistry and molecular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.The Journal of steroid biochemistry and molecular biology · 2017
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Immune Response: A Missed Opportunity Between Vitamin D and Radiotherapy.Frontiers in cell and developmental biology · 2021
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Nutrition, inflammation and cancer.Nature immunology · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Angeline A GiangrecoDepartment of Pathology, University of Illinois at Chicago, IL, USA.
Shweta DambalDepartment of Pathology, University of Illinois at Chicago, IL, USA.
Dennis WagnerDepartment of Nutritional Sciences and Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.
Theodorus Van der KwastDepartment of Pathology, University Health Network, University of Toronto, ON, Canada.
Reinhold ViethDepartment of Nutritional Sciences and Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.
Gail S PrinsUniversity of Illinois Cancer Center, Chicago, IL, USA; Department of Urology, University of Illinois at Chicago, IL, USA.
Larisa NonnDepartment of Pathology, University of Illinois at Chicago, IL, USA; University of Illinois Cancer Center, Chicago, IL, USA. Electronic address: lnonn@uic.edu.

Funding

Estrogen Receptors in Human Prostate Stem-Progenitor CellsR01CA172220 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PRINS, GAIL S · 2013 to 2017
$1.7M
Significance of Vitamin D-Regulated MicroRNAs in Prostate Cancer PreventionK22CA133105 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NONN, LARISA · 2009 to 2011
$498k
Vitamin D3 alters stromal-epithelial inflammatory crosstalk in human prostateR03CA172827 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NONN, LARISA · 2013 to 2014
$157k
NCI NIH HHS K22 CA133105NCI NIH HHS K22CA133105NCI NIH HHS R01 CA172220NCI NIH HHS R03 CA172827NCI NIH HHS R03CA172827
6 · The paper itself

Abstract

Previous work on vitamin D in the prostate has focused on the prostatic epithelium, from which prostate cancer arises. Prostatic epithelial cells are surrounded by stroma, which has well-established regulatory control over epithelial proliferation, differentiation, and the inflammatory response. Here we examined the regulation of vitamin D-related genes and inflammatory genes by 1α,25-dihydroxyvitamin D3 (1,25(OH)2D) in laser-capture microdissected prostate tissue from a vitamin D3 clinical trial and in an in vitro model that facilitates stromal-epithelial crosstalk. Analysis of the trial tissues showed that VDR was present in both cell types, whereas expression of the hydroxylases was the highest in the epithelium. Examination of gene expression by prostatic (1,25(OH)2D) concentrations showed that VDR was significantly lower in prostate tissues with the highest concentration of 1,25(OH)2D, and down-regulation of VDR by 1,25(OH) 2D was confirmed in the primary cell cultures. Analysis of inflammatory genes in the patient tissues revealed that IL-6 expression was the highest in the prostate stroma while PTGS2 (COX2) levels were lowest in the prostate cancer tissues from men in the highest tertile of prostatic 1,25(OH)2D. In vitro, TNF-α, IL-6 and IL-8 were suppressed by 1,25 (OH)2D in the primary epithelial cells, whereas TNF-α and PTGS2 were suppressed by 1,25(OH) 2D in the stromal cells. Importantly, the ability of 1,25(OH)2D to alter pro-inflammatory-induced changes in epithelial cell growth were dependent on the presence of the stromal cells. In summary, whereas both stromal and epithelial cells of the prostate express VDR and can presumably respond to 1,25(OH)2D, the prostatic epithelium appears to be the main producer of 1,25(OH)2D. Further, while the prostate epithelium was more responsive to the anti-inflammatory activity of 1,25 (OH)2D than stromal cells, stroma-epithelial crosstalk enhanced the phenotypic effects of 1,25(OH)2D and the inflammatory process in the prostate gland.

Indexed as

CalcitriolCell ProliferationCells, CulturedClinical Trials, Phase II as TopicEpitheliumGene Expression Regulation, NeoplasticHumansInflammation MediatorsIn Vitro TechniquesMaleProstateProstatic NeoplasmsReal-Time Polymerase Chain ReactionReceptors, CalcitriolReverse Transcriptase Polymerase Chain ReactionRNA, MessengerCalcitriolInflammation MediatorsReceptors, CalcitriolRNA, MessengerSteroid HydroxylasesVitaminsInflammationProstate epitheliumProstate stromaVitamin D

Identifiers

PMID25305352
PMCPMC4361379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.